NGFR and neoplasm: After the successful formation of the subcutaneous tumor, the immune system was reconstructed via an injection of CD3+ T cells (1*106), which had been separated from PBMCs and transfected with NGFR‐sh‐rAd, and PD‐1 mAb (Figure 7A).